459 Biomarkers
| ID | Biomarker | Location | Application | Reference |
|---|---|---|---|---|
| 20 | Chromosome 18q | Colon, Rectum | Prognosis | Jen J et al. N Engl J Med. 1994 |
| 30 | DNA index (DI) | Colon, Rectum | Prognosis | Tomoda H et al. J Surg Oncol. 1993 |
| 53 | Loss of heterozygosity (LOH) | Colon, Rectum | Prognosis | Ogunbiyi OA et al. Gastroenterology. 1997 |
| 57 | Loss of heterozygosity (LOH) | Colon, Rectum | Prognosis | Ogunbiyi OA et al. J Clin Oncol. 1998 |
| 59 | DNA index (DI) | Colon, Rectum | Prognosis | Tomoda H et al. Dis Colon Rectum. 1998 |
| 64 | Loss of heterozygosity (LOH) | Colon, Rectum | Treatment | Martínez-López E et al. Gastroenterology. 1998 |
| 72 | DNA index (DI) | Colon, Rectum | Prognosis | Yamamoto T et al. Surg Today. 1998 |
| 77 | Interleukin-2 (IL-2R) | Colon, Rectum | Prognosis | Saito H et al. Surg Today. 1998 |
| 89 | Loss of heterozygosity (LOH) | Colon, Rectum | Prognosis | Jernvall P et al. Br J Cancer. 1999 |
| 97 | Microsatellite instability (MSI) | Colon, Rectum | Prognosis | Halling KC et al. J Natl Cancer Inst. 1999 |
| 99 | P16 hypermethylation | Colon, Rectum | Prognosis | Liang JT et al. Oncology. 1999 |
| 104 | Microvessel count (MVC) | Colon, Rectum | Prognosis | Kimura T et al. Int J Oncol. 2000 |
| 108 | Interleukin-6 (IL-6) | Colon, Rectum | Prognosis | Belluco C et al. Ann Surg Oncol. 2000 |
| 119 | Microsatellite instability (MSI) | Colon, Rectum | Prognosis | Hemminki A et al. Gastroenterology. 2000 |
| 124 | Interleukin-12 (IL-12) | Colon, Rectum | Diagnosis | Nakayama Y et al. Anticancer Res. 2000 |
| 131 | Aneuploidy index (AI) | Colon, Rectum | Prognosis | Risques RA et al. Lab Invest. 2001 |
| 136 | MMP-2:TIMP-2 ratio | Colon, Rectum | Diagnosis | Chan CC et al. Int J Colorectal Dis. 2001 |
| 149 | P16 methylation | Colon, Rectum | Diagnosis | Zou HZ et al. Clin Cancer Res. 2002 |
| 154 | Apoptosis | Colon, Rectum | Prognosis, Treatment | Rödel C et al. Int J Radiat Oncol Biol Phys. 2002 |
| 166 | Microsatellite instability (MSI) | Colon, Rectum | Prognosis | Choi SW et al. Clin Cancer Res. 2002 |
| 172 | Microsatellite instability (MSI) | Rectum | Prognosis | Colombino M et al. Ann Oncol. 2002 |
| 205 | Microsatellite instability (MSI) | Colon, Rectum | Treatment | Brueckl WM et al. Anticancer Res. 2003 |
| 215 | CpG island methylator phenotype (CIMP) | Colon, Rectum | Treatment | Van Rijnsoever M et al. Clin Cancer Res. 2003 |
| 222 | Disseminated tumor cells (DTC) | Colon, Rectum | Prognosis | Linnemann U et al. Int J Colorectal Dis. 2004 |
| 256 | Loss of heterozygosity (LOH) | Colon, Rectum | Prognosis | Sarli L et al. Dis Colon Rectum. 2004 |
| 259 | Microsatellite instability (MSI) | Colon, Rectum | Treatment | Charara M et al. Anticancer Res. 2004 |
| 261 | Phase angle | Colon, Rectum | Prognosis | Gupta D et al. Am J Clin Nutr. 2004 |
| 274 | Loss of heterozygosity (LOH) | Colon, Rectum | Prognosis | Chang SC et al. World J Gastroenterol. 2005 |
| 281 | Fraction of genome altered (FGA), Clinical risk score (CRS) | Colon, Rectum | Prognosis | Mehta KR et al. Clin Cancer Res. 2005 |
| 284 | Interleukin 6 (IL-6), C-reactive protein (CRP) | Colon, Rectum | Prognosis | Nikiteas NI et al. World J Gastroenterol. 2005 |
| 285 | Microsatellite instability (MSI) | Colon, Rectum | Prognosis | Kohonen-Corish MR et al. J Clin Oncol. 2005 |
| 297 | Microsatellite instability (MSI) | Colon, Rectum | Prognosis | Kim YH et al. World J Gastroenterol. 2005 |
| 298 | Soluble FAS/soluble FASL ratio | Colon, Rectum | Treatment | Nadal C et al. Clin Cancer Res. 2005 |
| 306 | GNAS1 T393C | Colon, Rectum | Prognosis, Treatment | Frey UH et al. Clin Cancer Res. 2005 |
| 317 | DNA methylation | Colon, Rectum | Treatment | Leung WK et al. Am J Gastroenterol. 2005 |
| 321 | Inflammatory cell response | Colon, Rectum | Prognosis | Klintrup K et al. Eur J Cancer. 2005 |
| 324 | MMR status | Colon, Rectum | Prognosis | Jover R et al. Gut. 2006 |
| 326 | Microsatellite instability (MSI) | Colon, Rectum | Prognosis | Benatti P et al. Clin Cancer Res. 2005 |
| 327 | Angiogenesis | Colon, Rectum | Prognosis | Georgiou L et al. J Surg Res. 2006 |
| 328 | Urinary nucleosides | Colon, Rectum | Diagnosis | Feng B et al. J Gastroenterol Hepatol. 2005 |
| 358 | Visceral adiposity | Colon, Rectum | Prognosis | Moon HG et al. Ann Surg Oncol. 2008 |
| 361 | P16 hypermethylation | Colon, Rectum | Prognosis | Wettergren Y et al. Mol Med. 2008 |
| 365 | Receptor for hyaluronic acid mediated motility (RHAMM) | Colon, Rectum | Prognosis | Zlobec I et al. Gut. 2008 |
| 368 | Extramural vascular invasion (EVI) | Colon, Rectum | Prognosis | Courtney ED et al. Colorectal Dis. 2009 |
| 373 | Apoptotic body index (ABI) | Colon, Rectum | Prognosis | El-Awady S et al. Hepatogastroenterology. 2008 |
| 375 | GSTP1 Ile105Val polymorphism | Colon, Rectum | Treatment | Agostini M et al. Drugs Aging. 2008 |
| 378 | Tumor doubling time (TDT) | Colon, Rectum | Prognosis | Tomimaru Y et al. Dig Surg. 2008 |
| 380 | Circulating tumor cells (CTCs) | Colon, Rectum | Prognosis | Cohen SJ et al. J Clin Oncol. 2008 |
| 381 | Microsatellite instability (MSI) | Colon, Rectum | Treatment | Müller CI et al. Int J Colorectal Dis. 2008 |
| 386 | Microvessel density (MVD) | Colon, Rectum | Prognosis | Yodavudh S et al. J Med Assoc Thai. 2008 |
| 387 | Microtubule associated protein 7 (Map7)/B2M | Colon | Prognosis | Blum C et al. Int J Oncol. 2008 |
| 388 | TS1494del6 polymorphism | Rectum | Treatment | Stoehlmacher J et al. Cancer Lett. 2008 |
| 390 | CpG island methylator phenotype (CIMP), BRAF | Colon | Prognosis | Ogino S et al. Gut. 2009 |
| 418 | Secernin 1 (SCRN1) | No Data | Prognosis | Miyoshi N et al. J Surg Oncol. 2010 |
| 421 | Apical node metastasis | Colon, Rectum | Prognosis | Ang CW et al. Colorectal Dis. 2011 |
| 430 | Carbohydrate antigen 125 (CA125) | Colon, Rectum | Prognosis | Yang XQ et al. Med Oncol. 2011 |
| 443 | Dermokine (DK) | No Data | Diagnosis | Taqi T et al. J Gastroenterol. 2010 |
| 449 | γ-Catenin | Colon, Rectum | Prognosis | Nagel JM et al. Int J Colorectal Dis. 2010 |
| 453 | CCTζ-1 | Colon, Rectum | Prognosis | Qian-Lin Z et al. J Surg Oncol. 2010 |
| 473 | Osteoprotegerin (OPG) | No Data | Prognosis, Treatment | Tsukamoto S et al. Clin Cancer Res. 2011 |
| 480 | Adrenomedullin (ADM) | Colon, Rectum | Prognosis | Uemura M et al. Anticancer Res. 2011 |
| 482 | Interleukin 17 (IL-17) | Colon, Rectum | Prognosis | Liu J et al. Biochem Biophys Res Commun. 2011 |
| 484 | Lymphopenia | Colon, Rectum | Prognosis | Cézé N et al. Cancer Chemother Pharmacol. 2011 |
| 492 | CEA | Colon, Rectum | Prognosis | Lin JK et al. Int J Colorectal Dis. 2011 |
| 496 | MGb2-Ag/TRAK1 | No Data | Prognosis | An Y et al. Int J Colorectal Dis. 2011 |
| 499 | Immune cells (iCD10) | Colon, Rectum | Prognosis | Khanh do T et al. Cancer Sci. 2011 |
| 516 | MSCs, CD34b LCs | No Data | Diagnosis | Bellows CF et al. Cancer Epidemiol Biomarkers Prev. 2011 |
| 521 | Fucosylated haptoglobin (Fuc-Hpt) | No Data | Prognosis | Takeda Y et al. Cancer. 2012 |
| 525 | Thrombocytosis | Colon, Rectum | Prognosis | Sasaki K et al. World J Surg. 2012 |
| 529 | Microsatellite instability (MSI) | Colon, Rectum | Prognosis | Hong SP et al. Eur J Cancer. 2012 |
| 532 | Onodera's prognostic nutritional index (OPNI) | Rectum | Prognosis | Nozoe T et al. Surg Today. 2012 |
| 537 | Serum levels of soluble E-cadherin (sE-cadherin) | No Data | Prognosis | Okugawa Y et al. J Surg Res. 2012 |
| 544 | Helicase-like transcription factor (HLTF), hyperplastic polyposis 1 (HPP1) | Colon, Rectum | Prognosis | Philipp AB et al. Int J Cancer. 2012 |
| 551 | NHLN | Colon, Rectum | Prognosis | La Torre M et al. J Surg Oncol. 2012 |
| 562 | Nanog | No Data | Prognosis | Xu F et al. Dig Dis Sci. 2012 |
| 567 | Activating transcription factor 1 (ATF1) | Colon, Rectum | Prognosis | Huang GL et al. Asian Pac J Cancer Prev. 2012 |
| 569 | Circulating tumor cells (CTCs) | Colon, Rectum | Prognosis | Sastre J et al. Oncologist. 2012 |
| 574 | Carcinoembryonic antigen (CEA) | Rectum | Prognosis | Tarantino I et al. Br J Cancer. 2012 |
| 577 | PIK3CA mutation, methylation | No Data | Prognosis | Iida S et al. Oncol Lett. 2012 |
| 584 | Glasgow prognostic score (GPS) | Colon, Rectum | Prognosis | Furukawa K et al. Oncol Lett. 2012 |
| 587 | Phospho-ERK | No Data | Prognosis | Tai CJ et al. Pol J Pathol. 2012 |
| 588 | XIAP (X-linked inhibitor of apoptosis) | Rectum | Prognosis | Moussata D et al. Am J Pathol. 2012 |
| 597 | Combination of CFD, CEA, CA19-9 | Rectum | Diagnosis | Qi J et al. Clin Biochem. 2013 |
| 601 | eSNPs in CD47 | Colon, Rectum | Prognosis | Lascorz J et al. Int J Colorectal Dis. 2013 |
| 612 | PPP1R13L rs1970764 variant | Colon, Rectum | Prognosis | Chae YS et al. J Cancer Res Clin Oncol. 2013 |
| 617 | Microsatellite instability (MSI) | Colon, Rectum | Prognosis | Merok MA et al. Ann Oncol. 2013 |
| 618 | The lymph node ratio (LNR) | No Data | Prognosis | Allaix ME et al. Surg Endosc. 2013 |
| 622 | Bevacizumab-related proteinuria | Colon, Rectum | Diagnosis | Lwasa S et al. Anticancer Res. 2013 |
| 626 | Alpha 1-antitrypsin, the levels of mRNA expression of MMP7, COX-2, Upar | No Data | Diagnosis | Bujanda L et al. PLoS One. 2013 |
| 643 | Preoperative platelets | Colon, Rectum | Prognosis | Wan S et al. J Gastrointest Cancer. 2013 |
| 648 | Lymph node ratio (LNR) | Rectum | Prognosis | La Torre M et al. Colorectal Dis. 2013 |
| 652 | Hyperphosphatemia | Colon, Rectum | Prognosis | Ye Z et al. J Gastroenterol Hepatol. 2013 |
| 656 | 12-LOX 261Arg > Gln polymorphism | Colon, Rectum | Prognosis | Li S et al. Fam Cancer. 2013 |
| 658 | MPO+ cell infiltration | No Data | Prognosis | Droeser RA et al. PLoS One. 2013 |
| 662 | CCL21 | No Data | Prognosis | Zou Y et al. Oncol Rep. 2013 |
| 663 | Serum carcinoembryonic antigen (s-CEA) | Colon, Rectum | Prognosis | Kim CW et al. Ann Surg Oncol. 2013 |
| 664 | Yes-associated protein (YAP), transcriptional co-activator with PDZ-binding motif (TAZ) | Rectum | Prognosis | Wang L et al. PLoS One. 2013 |
| 673 | COP-NLR (COmbination of Platelet count, Neutrophil to Lymphocyte Ratio) | No Data | Prognosis | Ishizuka M et al. Br J Cancer. 2013 |
| 677 | Carboxypeptidase E (CPE)-ΔN | Colon, Rectum | Prognosis | Zhou K et al. Tumour Biol. 2013 |
| 681 | Lymph node ratio (LNR) | No Data | Prognosis | Nadoshan JJ et al. Asian Pac J Cancer Prev. 2013 |
| 683 | Neutrophil lymphocyte ratio (NLR) | No Data | Prognosis | Shibutani M et al. Anticancer Res. 2013 |
| 692 | Slug, Vimentin | No Data | Diagnosis, Prognosis | Toiyama Y et al. Carcinogenesis. 2013 |
| 694 | Combination of circulating tumor cells plus KRAS | Colon, Rectum | Prognosis | Sastre J et al. Clin Colorectal Cancer. 2013 |
| 695 | Interleukin-10 (IL10) | No Data | Prognosis | Ting WC et al. J Korean Med Sci. 2013 |
| 696 | Perineural invasion (PNI) | Colon, Rectum | Prognosis | Ueno H et al. Am J Surg Pathol. 2013 |
| 697 | Neutropenia | No Data | Prognosis | Sunaga T et al. Eur J Cancer Care (Engl). 2014 |
| 698 | Interleukin 35 (IL-35) | No Data | Prognosis | Zeng JC et al. Int J Clin Exp Pathol. 2013 |
| 699 | Microsatellite instability (MSI), Chromosomal instability (CIN) | Colon, Rectum | Prognosis | Mouradov D et al. Am J Gastroenterol. 2013 |
| 701 | P62/sequestosome-1 | No Data | Treatment | Ren F et al. Mol Cell Biochem. 2014 |
| 704 | Neutrophil lymphocyte ratio (NLR) | Colon, Rectum | Prognosis | Malietzis G et al. Ann Surg. 2014 |
| 705 | Intraoperative blood loss (IBL) | No Data | Prognosis | Jiang W et al. PLoS One. 2013 |
| 706 | Extramural vascular invasion (EVI) | Rectum | Prognosis | Bhangu A et al. Colorectal Dis. 2013 |
| 708 | Peritumoral deposits (PTDs) | Colon, Rectum | Prognosis | Ueno H et al. Am J Surg. 2014 |
| 712 | Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) | Rectum | Prognosis | Lollert A et al. J Magn Reson Imaging. 2014 |
| 720 | Crohn's like lymphoid reaction (CLR) | Colon, Rectum | Prognosis | Väyrynen JP et al. Int J Cancer. 2014 |
| 745 | TWIST1, SNAI1 | Colon | Prognosis | Kim YH et al. Oncol Rep. 2014 |
| 758 | Fusobacterium nucleatum (Fn) | Colon, Rectum | Diagnosis, Prognosis | Flanagan L et al. Eur J Clin Microbiol Infect Dis. 2014 |
| 764 | Immunoscore | Rectum | Prognosis | Anitei MG et al. Anitei MG. 2017 |
| 766 | P21, CD166 | No Data | Prognosis | Sim SH et al. BMC Cancer. 2014 |
| 767 | Colon cancer-specific antigen-2 (CCSA-2) | No Data | Diagnosis, Prognosis | Xue G et al. PLoS One. 2014 |
| 771 | Interleukin-like EMT inducer (ILEI) | Colon, Rectum | Prognosis | Gao ZH et al. Histopathology. 2014 |
| 774 | Neutrophil lymphocyte ratio (NLR) | No Data | Prognosis | Ozdemir Y et al. Asian Pac J Cancer Prev. 2014 |
| 776 | Nutritional risk screening (NRS) | Colon, Rectum | Prognosis | Kwag SJ et al. Ann Surg Treat Res. 2014 |
| 777 | Aldh1, Survivin,, EpCAM | Colon, Rectum | Prognosis | Goossens-Beumer IJ et al. Br J Cancer. 2014 |
| 781 | Interleukin-13 (IL-13) | No Data | Prognosis | Saigusa S et al. Int Surg. 2014 |
| 784 | β1-Integrin | Colon, Rectum | Prognosis | Oh BY et al. Ann Coloproctol. 2014 |
| 791 | Contrast-enhanced ultrasonography (CEUS) | Rectum | Prognosis | Wang Y et al. Biomed Res Int. 2014 |
| 792 | β-Catenin, E-Cadherin | No Data | Prognosis | Bruun J et al. Front Oncol. 2014 |
| 797 | Vascular invasion | Colon, Rectum | Prognosis | Fujii T et al. Anticancer Res. 2014 |
| 798 | TAC1, SEPT9 methylation | No Data | Prognosis | Tham C et al. Cancer. 2014 |
| 799 | Heme oxygenase-1 (HO-1)/carbon monoxide (CO) | No Data | Diagnosis, Prognosis | Yin H et al. BMC Cancer. 2014 |
| 801 | CHFR promoter CpG island methylation | No Data | Prognosis | Cleven AH et al. Clin Cancer Res. 2014 |
| 805 | WNT inhibitory factor 1 (WIF1), secreted frizzled related protein 1 (SFRP1) | No Data | Prognosis | Huang S et al. Biomed Res Int. 2014 |
| 815 | Standardized uptake values of the regional lymph nodes (SUVn) | No Data | Prognosis | Byun BH et al. Eur J Nucl Med Mol Imaging. 2014 |
| 820 | O6-methylguanine DNA methyltransferase (MGMT), CD133 | No Data | Prognosis | Oliver JA et al. BMC Cancer. 2014 |
| 826 | IL-17, Tr1-positive cells | No Data | Prognosis | Chen J et al. Med Oncol. 2014 |
| 827 | The lymph node ratio (LNR) | No Data | Prognosis | Zeng WG et al. Asian Pac J Cancer Prev. 2014 |
| 829 | Histone modifications H3K4me3, H3K9me3, H4K20me3 | Colon, Rectum | Prognosis | Benard A et al. BMC Cancer. 2014 |
| 830 | 19 genes regulated by TREM1 or CTGF activation (TCA19) | No Data | Prognosis | Kim SK et al. Mol Oncol. 2014 |
| 839 | Inflammatory state | No Data | Prognosis | Hamilton TD et al. BMC Cancer. 2014 |
| 842 | Lymph node ratio (LNR) | Colon, Rectum | Prognosis | Costi R et al. J Gastrointest Surg. 2014 |
| 852 | Neutrophil lymphocyte ratio (NLR) | No Data | Prognosis | Azab B et al. Cancer Biomark. 2014 |
| 853 | Interleukin 8 (IL-8) | No Data | Prognosis | Bălăşoiu M et al. Rom J Morphol Embryol. 2014 |
| 860 | Integrin αvβ6, Ets-1 | Colon, Rectum | Prognosis | Peng C et al. Cell Biosci. 2014 |
| 873 | Interleukin-36α (IL-36α) | Colon, Rectum | Prognosis | Wang ZS et al. Int J Clin Exp Pathol. 2014 |
| 875 | Circumferential resection margin involvement (R1) | No Data | Prognosis | Khan MA et al. Colorectal Dis. 2015 |
| 877 | Circulating tumor cells (CTCs) | Colon, Rectum | Prognosis | Bork U et al. Br J Cancer. 2015 |
| 882 | Integrin-β1 (ITGB1) | Colon, Rectum | Prognosis | Zhou F et al. Cancer Chemother Pharmacol. 2015 |
| 888 | Platelet lymphocyte ratio (PLR) | Colon, Rectum | Prognosis | Ozawa T et al. Int J Colorectal Dis. 2015 |
| 894 | E2F1 | Colon, Rectum | Diagnosis, Prognosis | Fang Z et al. Biochem Biophys Res Commun. 2015 |
| 901 | Endothelial cell-specific molecule-1 (ESM-1) | Colon, Rectum | Prognosis | Jiang H et al. Genet Mol Res. 2015 |
| 915 | Lymphocyte to monocyte ratio (LMR) | Colon, Rectum | Prognosis | Shibutani M et al. World J Gastroenterol. 2015 |
| 932 | Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) | No Data | Diagnosis, Prognosis | Xu W et al. Discov Med. 2015 |
| 935 | Serum uric acid | Colon | Prognosis | Selcukbiricik F et al. Clin Transl Oncol. 2016 |
| 936 | micrometastasis volume | Colon, Rectum | Prognosis | Yamamoto H et al. Clin Cancer Res. 2016 |
| 952 | PRKDC | No Data | Prognosis, Treatment | Sun S et al. Gene. 2016 |
| 954 | Platelet lymphocyte ratio (PLR) | Colon, Rectum | Prognosis | Zou ZY et al. Oncol Lett. 2016 |
| 955 | Neutrophil lymphocyte ratio (NLR) | Colon, Rectum | Prognosis | Zou ZY et al. Oncol Lett. 2016 |
| 958 | Cancer susceptibility candidate 11 (CASC11) | No Data | Diagnosis, Treatment | Zhang Z et al. Cancer Lett. 2016 |
| 959 | Sciellin (SCEL) | No Data | Treatment | Chou CK et al. Oncotarget. 2016 |
| 968 | Lymphocyte to monocyte ratio (LMR) | Colon, Rectum | Prognosis | Chan JC et al. Ann Surg. 2017 |
| 973 | Tumour-associated macrophages (TAMs) | Colon, Rectum | Prognosis | Marech I et al. J Cell Mol Med. 2016 |
| 978 | Tumour necrosis percentage | No Data | Prognosis | Väyrynen SA et al. Br J Cancer. 2016 |
| 979 | prognostic nutritional index (PNI) | Colon, Rectum | Prognosis | Park BK et al. J Surg Oncol. 2016 |
| 1009 | Lymphovascular, perineural invasion (LVI, PNI) | Colon, Rectum | Prognosis | Al-Sukhni E et al. Int J Surg. 2017 |
| 1015 | Fecal Bacteria | Colon | Diagnosis | Liang Q et al. Clin Cancer Res. 2017 |
| 1018 | Interleukin 6 (IL-6) | Colon, Rectum | Prognosis | Thomsen M et al. Oncotarget. 2016 |
| 1027 | CD133+, CD133+CD54+CD44+ cellular subpopulations | Colon, Rectum | Prognosis | Fang C et al. Oncotarget. 2016 |
| 1031 | Dieckol | No Data | Prognosis | Jeong SH et al. Mol Med Rep. 2016 |
| 1036 | Combination of hERG1 positivity, Glut-1 negativity | Colon, Rectum | Prognosis | Muratori L et al. Onco Targets Ther. 2016 |
| 1039 | Fusobacterium nucleatum (Fn) | Colon | Diagnosis | Wong SH et al. Gut. 2016 |
| 1042 | Interleukin-23 (IL-23) | Colon, Rectum | Prognosis | Hu WH et al. J Surg Oncol. 2017 |
| 1043 | Interleukin 23 (IL-23) | Colon, Rectum | Prognosis | Hu WH et al. J Surg Oncol. 2017 |
| 1044 | C-reactive protein to albumin (CRP/ALB) | Colon, Rectum | Prognosis | Shibutani M et al. Springerplus. 2016 |
| 1049 | Total lesion glycolysis (TLG) | Colon, Rectum | Treatment | Lim Y et al. Eur J Nucl Med Mol Imaging. 2017 |
| 1052 | Neutrophil lymphocyte ratio (NLR) | Colon, Rectum | Prognosis | Oh SY et al. J Surg Res. 2017 |
| 1055 | WNT5A methylation status | Colon, Rectum | Prognosis, Treatment | Jiang G et al. Genet Test Mol Biomarkers. 2017 |
| 1058 | RAS/PIK3CA/BRAF mutations | Colon, Rectum | Treatment | Nakayama I et al. BMC Cancer. 2017 |
| 1059 | Perineural invasion (PNI) | Colon, Rectum | Prognosis | Alotaibi AM et al. Ann Surg Oncol. 2017 |
| 1062 | Choline | Colon, Rectum | Prognosis | Guertin KA et al. Cancer Epidemiol Biomarkers Prev. 2017 |
| 1064 | Circulating (CTC) or disseminated tumor cells (DTC) | Colon | Prognosis | Hinz S et al. BMC Cancer. 2017 |
| 1065 | The CpG island methylator phenotype (CIMP) | Colon, Rectum | Prognosis | Kim CH et al. J Gastroenterol Hepatol. 2017 |
| 1078 | Platelet-lymphocyte ratio (PLR) | Colon, Rectum | Prognosis | Bong TS et al. Int J Clin Oncol. 2017 |
| 1082 | Enterotoxigenic Bacteroides fragilis (ETBF) | Colon, Rectum | Diagnosis | Purcell RV et al. PLoS One. 2017 |
| 1088 | CYFRA 21-1 | Colon, Rectum | Diagnosis | Lim DH et al. J Clin Lab Anal. 2017 |
| 1100 | Prognostic nutritional index (PNI) | Colon, Rectum | Prognosis | Noh GT et al. J Cancer Res Clin Oncol. 2017 |
| 1102 | Derived neutrophil to lymphocyte ratio (dNLR) | Colon, Rectum | Prognosis | Wood G et al. Anticancer Drugs. 2017 |
| 1105 | Body mass index | Colon, Rectum | Prognosis | He Y et al. Dis Colon Rectum. 2017 |
| 1111 | Prognostic nutritional index (PNI) | Colon, Rectum | Prognosis | Cao X et al. Nutr Cancer. 2017 |
| 1115 | Neutrophil lymphocyte ratio (NLR) | Colon, Rectum | Prognosis | Sung S et al. PLoS One. 2017 |
| 1119 | Circulating tumor cells (CTCs) | Colon, Rectum | Diagnosis | Lyberopoulou A et al. Anticancer Res. 2017 |
| 1120 | Platelet lymphocyte ratio (PLR) | Colon, Rectum | Prognosis | Lee IH et al. Anticancer Res. 2017 |
| 1122 | Apparent diffusion coefficient (ADC) | Colon, Rectum | Prognosis | Schmeel FC et al. J Cancer Res Clin Oncol. 2017 |
| 1127 | TGFβ1 R25P | Colon, Rectum | Treatment | Smith JJ et al. Int J Radiat Oncol Biol Phys. 2017 |
| 1131 | UMPS 638 CC genotype | Colon, Rectum | Treatment | Kim SY et al. Radiat Oncol. 2017 |
| 1132 | Interleukin-6 (IL-6) | Colon, Rectum | Prognosis | Zeng J et al. World J Gastroenterol. 2017 |
| 1140 | CA125-rich exosomes | No Data | Diagnosis, Prognosis | Xiao, Y et al. Clin Chim Acta. 2019 |
| 1144 | ALRI (aspartate aminotransferase-lynphocyte ratio) | Colon, Rectum | Prognosis | Casadei Gardini, A et al. Onco Targets Ther. 2018 |
| 1164 | urinary 8-oxodG and SUA | Colon, Rectum | Prognosis | Mao, L et al. Onco Targets Ther. 2018 |
| 1183 | D-dimer | Colon, Rectum | Prognosis | Guo, Y et al. Cancer Manag Res. 2018 |
| 1185 | Neutrophil-to lymphocyte ratio (NLR) and platelet-to lymphocyte ratio (PLR) | No Data | No Data | Cruz-Ramos, M et al. J Geriatr Oncol. 2019 |
| 1194 | PEA15 | No Data | No Data | Tang, B et al. Oncol Rep. 2019 |
| 1195 | validates leukocytosis | Colon, Rectum | Prognosis | Hu, X et al. Front Immunol. 2018 |
| 1196 | ITCIL CD8+ lymphocytes | Colon | Prognosis | Nazemalhosseini-Mojarad, E et al. J Cell Physiol. 2019 |
| 1197 | metastasis-associated in colon cancer-1 (MACC1) | No Data | Diagnosis, Prognosis | Lin, A et al. J Cell Mol Med. 2019 |
| 1199 | Ago2-miR-200c | Colon, Rectum | No Data | Fuji, T et al. Int J Cancer. 2019 |
| 1200 | lymphocyte-monocyte-neutrophil (LMN) score | Colon, Rectum | Prognosis | Tanio, A et al. Surg Today. 2019 |
| 1209 | Tumor deposits | Colon, Rectum | Prognosis | Basnet, S et al. J Cancer. 2018 |
| 1210 | elevated platelet count | Rectum | Prognosis | Belluco, C et al. BMC Cancer. 2018 |
| 1217 | elastic lamina invasion (ELI) | Colon, Rectum | Prognosis | Liang, W Y et al. Hum Pathol. 2019 |
| 1219 | Long interspersed nucleotide element-1 (LINE-1) methylation | No Data | Diagnosis, Prognosis | Kerachian, M A et al. Clin Chim Acta. 2019 |
| 1222 | lymphocyte-to-monocyte ratio and ypN status | Rectum | Prognosis | Yamamoto, A et al. Dis Colon Rectum. 2019 |
| 1232 | RelB | Colon | Prognosis | Zhou, X et al. Cancer Cell Int. 2018 |
| 1238 | Symptomatic venous thromboembolism (VTE) | Colon, Rectum | Prognosis | Bozkaya, Y et al. J Cancer Res Ther. 2018 |
| 1242 | CD44 | Rectum | Prognosis | Kim, J et al. Anticancer Res. 2018 |
| 1243 | Neutrophil to lymphocyte ratio (NLR) | Rectum | Prognosis | Renaud, S et al. Eur J Cardiothorac Surg. 2019 |
| 1244 | Neutrophil to lymphocyte ratio (NLR) | Colon, Rectum | Prognosis | Dimitriou, N et al. BMC Cancer. 2018 |
| 1263 | 18F-FMISO uptake | No Data | No Data | Zhang, M et al. Sci Rep. 2018 |
| 1264 | linc01296/miR-26a/GALNT3 | No Data | Diagnosis | Liu, B et al. J Exp Clin Cancer Res. 2018 |
| 1271 | proliferating cell nuclear antigen (PCNA) | No Data | Prognosis | Zhou, H et al. Medicine (Baltimore). 2018 |
| 1277 | fibrinogen and neutrophil-lymphocyte ratio | Colon, Rectum | Prognosis | Li, X et al. Cancer Manag Res. 2018 |
| 1278 | Immunoscore (IS) | Colon | Prognosis | Yomoda, T et al. Ann Surg Oncol. 2019 |
| 1286 | SIRT2/STAT3/VEGFA | No Data | Prognosis | Hu, F et al. Cell Death Dis. 2018 |
| 1290 | Combination of D-dimer and carcinoembryonic antigen levels | Colon, Rectum | Prognosis | Li, H et al. J Cell Biochem. 2018 |
| 1292 | Up-regulated genes of SLC10A1, MAPT, SHANK2, PTH1R, and C2, as well as down-regulated genes of CAB39, CFLAR, CTSC, THBS1, and TRAPPC3 | No Data | No Data | Liu, J et al. Dig Dis Sci. 2019 |
| 1293 | uCyr61 and uTFF3 | No Data | Diagnosis | Shimura, T et al. Transl Oncol. 2019 |
| 1294 | H3K79me3 | Rectum | Prognosis | Kari, V et al. Clin Epigenetics. 2019 |
| 1304 | drop in BMI or weight | Colon, Rectum | No Data | Shahjehan, F et al. Front Oncol. 2018 |
| 1305 | autophagosomes | No Data | No Data | Wang, J et al. Biochem J. 2019 |
| 1306 | Circulating inflammation signature | No Data | No Data | Varkaris, A et al. Br J Cancer. 2019 |
| 1307 | Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) | No Data | No Data | Lu, X et al. Cancer Manag Res. 2019 |
| 1308 | angiogenic dHGP | No Data | Prognosis | Galjart, B et al. Angiogenesis. 2019 |
| 1310 | Red blood cell distribution width (RDW) | Colon, Rectum | Diagnosis, Prognosis | Song, Y et al. Biomed Res Int. 2018 |
| 1311 | Combined activity of the estrogen receptor(ER) and BRAF/MEK pathways | No Data | Prognosis | Liu, D et al. Cell Oncol (Dordr). 2019 |
| 1313 | Preoperative neutrophil-to-lymphocyte ratio (NLR) | No Data | Prognosis | Li, H et al. Medicine (Baltimore). 2019 |
| 1317 | serum level of octanoic acid | No Data | Prognosis | Iemoto, T et al. Oncol Lett. 2019 |
| 1319 | serum high-density lipoprotein cholesterol (HDL-C) and serum albumin (ALB) levels (HA score) | No Data | Prognosis | Huang, H et al. J Cancer. 2019 |
| 1325 | tumor-associated macrophage (TAM) infiltration | Colon | No Data | Dost Gunay, F S et al. Clin Colorectal Cancer. 2019 |
| 1326 | CD8 and IDO1 | Rectum | Prognosis | Schollbach, J et al. Cancer Immunol Immunother. 2019 |
| 1329 | convolutional neural networks (CNNs) | No Data | Prognosis | Kather, J N et al. PLoS Med. 2019 |
| 1330 | iNOS/NO system | Colon, Rectum | Prognosis, Treatment | Benkhelifa, S et al. Inflammopharmacology. 2019 |
| 1332 | Fat-free muscle area (FFMA) | No Data | Prognosis | Faron, A et al. Eur Radiol. 2019 |
| 1337 | C-reactive protein-to-albumin ratio (CAR) | No Data | No Data | Shibutani, M et al. Anticancer Res. 2019 |
| 1345 | bermekimab | No Data | Treatment | Kurzrock, R et al. Oncoimmunology. 2019 |
| 1348 | DNA repair capacity | No Data | Prognosis | Tolan, H K et al. Niger J Clin Pract. 2019 |
| 1352 | visceral adipose tissue density | No Data | Prognosis | Charette, N et al. BMC Cancer. 2019 |
| 1365 | the serum levels of Trx1/RTrx1, TGFβ/interleukin (IL)6 and TGFβ/IL4 combinations and the sCD30, IFNγ and IL2 combination | No Data | No Data | Berghella, A M et al. World J Gastrointest Oncol. 2019 |
| 1373 | growth differentiation factor 15 (GDF-15) | No Data | Diagnosis | Wang, Y et al. BMC Cancer. 2019 |
| 1377 | Lymphocyte-C-reactive Protein Ratio | No Data | No Data | Okugawa, Y et al. Ann Surg. 2019 |
| 1395 | micronuclei (MN) frequency | No Data | Prognosis | Nikolouzakis, T K et al. Oncol Lett. 2019 |
| 1405 | CD8+ iTILs and ITB | Rectum | No Data | Huang, Y et al. Biosci Rep. 2019 |
| 1407 | tumor heterogeneity (TH) index | Colon, Rectum | Prognosis | Oh, B Y et al. Sci Rep. 2019 |
| 1416 | red cell distribution width (RDW)-to-platelet ratio (RPR) | Colon, Rectum | No Data | Bilgin, B et al. J Cancer Res Ther. 2019 |
| 1421 | advanced lung cancer inflammation index (ALI) | No Data | Prognosis | Shibutani, M et al. BMC Cancer. 2019 |
| 1424 | p53-mild expression status | Colon, Rectum | Prognosis | Oh, H J et al. Br J Cancer. 2019 |
| 1437 | 8-oxodGu | Colon, Rectum | Prognosis | Burlaka, A A et al. Exp Oncol. 2019 |
| 1557 | miR-182/-135b/ST6GALNAC2/PI3K/AKT | Colon, Rectum | Treatment | Jia L et al. Dig Dis Sci. 2017 |
| 1590 | MiR-216b | Colon, Rectum | Diagnosis, Prognosis | Chen X et al. Am J Cancer Res. 2017 |
| 1591 | circRNA0003906 | Colon, Rectum | Diagnosis, Treatment | Zhuo F et al. Onco Targets Ther. 2017 |
| 1658 | upper-extremity deep venous thrombosis (U-DVT) | Colon, Rectum | Prognosis | Adelborg K et al. Thromb Res. 2018 |
| 1724 | apoptotic index | Colon, Rectum | Prognosis | Kunac N et al. Appl Immunohistochem Mol Morphol. 2019 |
| 1726 | ratio-based B-vitamin markers | Colon, Rectum | Prognosis | Gylling B et al. Int J Cancer. 2019 |
| 1727 | circulating fibrinogen to pre-albumin ratio——"Fibrinogen/pre-Albumin" | Colon, Rectum | Diagnosis | Sun F et al. J Clin Lab Anal. 2019 |
| 1728 | KRAS | Colon, Rectum | Prognosis | Eilertsen IA et al. Int J Cancer. 2019 |
| 1730 | BRAF | Colon, Rectum | Prognosis | Bläker H et al. Clin Gastroenterol Hepatol. 2019 |
| 1731 | rs27437 in SLC22A5 | Colon, Rectum | Diagnosis | Zou D et al. Eur J Cancer. 2018 |
| 1733 | long non-coding RNA FOXD2-AS1, miR-185-5p | Colon, Rectum | Diagnosis, Prognosis | Zhu Y et al. Cancer Sci. 2018 |
| 1734 | platelet indices | Colon, Rectum | Diagnosis, Prognosis | Zhu X et al. Sci Rep. 2018 |
| 1741 | DNA hydroxymethylation | Colon, Rectum | Prognosis | Zhong A et al. J Surg Oncol. 2018 |
| 1746 | collagen type I alpha 1 (COL1A1) | Colon, Rectum | Prognosis, Treatment | Zhang Z et al. Int J Oncol. 2018 |
| 1748 | CREPT | Colon, Rectum | Prognosis | Zhang Y et al. Oncogene. 2018 |
| 1749 | MCV | Rectum | Prognosis | Zhang WY et al. Gastroenterol Res Pract. 2017 |
| 1753 | MET | Colon, Rectum | Diagnosis, Prognosis | Zhang M et al. Hum Pathol. 2018 |
| 1761 | homeobox (HOX) / HOXA10 | Colon, Rectum | Prognosis | Yuan Y et al. Genet Test Mol Biomarkers. 2018 |
| 1768 | PCDHB3 | Colon, Rectum | Prognosis | Ye W et al. J Pathol. 2018 |
| 1771 | RAS/BRAF | Colon, Rectum | Prognosis | Yao J et al. Can J Gastroenterol Hepatol. 2018 |
| 1779 | retinoic acid-induced 2 (RAI2) | Colon, Rectum | Prognosis | Yan W et al. Clin Epigenetics. 2018 |
| 1783 | HMGA2 | Colon, Rectum | Prognosis, Treatment | Xu X et al. Oncotarget. 2018 |
| 1789 | tumor-infiltrating lymphocytes (TILs) | Colon, Rectum | Prognosis | Xie QK et al. Cancer Manag Res. 2018 |
| 1795 | Uev1A | Colon, Rectum | Prognosis, Treatment | Wu Z et al. Oncotarget. 2018 |
| 1796 | CG/GG at CRYAB C-802G (rs14133) | Colon, Rectum | Prognosis | Wu X et al. Sci Rep. 2018 |
| 1798 | hyperglycemia/ high glucose | Colon, Rectum | Prognosis | Wu J et al. Exp Ther Med. 2018 |
| 1802 | tumour-infiltrating lymphocyte (TIL) response /deficient DNA mismatch repair (dMMR) TIL/MMR(ratio) | Colon, Rectum | Prognosis | Williams DS et al. Gut. 2018 |
| 1815 | circulating tumor cells (CTCs), epithelial-mesenchymal transition(EMT) phenotypes | Colon, Rectum | Prognosis | Wang W et al. Cell Oncol (Dordr). 2018 |
| 1816 | PIK3CA (mutation)/LGR5(+) | Colon, Rectum | Prognosis | Wang Q et al. Cell Death Dis. 2018 |
| 1819 | cluster of differentiation 24 (CD24) | Colon, Rectum | Prognosis | Wang JL et al. Clin Lab. 2018 |
| 1830 | chromosome 18q11.2-q12.1 | Colon, Rectum | Prognosis | van Dijk E et al. J Clin Oncol. 2018 |
| 1831 | MACROD2 | Colon | Prognosis | van den Broek E et al. Oncotarget. 2018 |
| 1832 | leukocytes | Rectum | Prognosis | Vallard A et al. Oncotarget. 2018 |
| 1833 | NDRG1, NDRG2 and NDRG4 | Colon, Rectum | Prognosis | Vaes N et al. Biochim Biophys Acta Gen Subj. 2018 |
| 1838 | albumin-globulin ratio (AGR) | Rectum | Prognosis | Toiyama Y et al. Oncology. 2018 |
| 1839 | RAS/RAF(ratio) | Colon, Rectum | Prognosis | Thomsen CB et al. J Exp Clin Cancer Res. 2018 |
| 1843 | coNLR-PLR | Colon, Rectum | Prognosis | Tao Y et al. Cancer Med. 2018 |
| 1850 | ascorbate | Colon, Rectum | Prognosis | Starczak M et al. J Transl Med. 2018 |
| 1852 | trifluridine/tipiracil (TAS-102) | Colon, Rectum | Diagnosis | Skuja E et al. Mol Clin Oncol. 2018 |
| 1854 | NDRG2 and Skp2 | Colon, Rectum | Diagnosis, Prognosis | Shen L et al. Oncogene. 2018 |
| 1858 | the G allele of XRCC2; AGC>AGG, p.Ser150Arg | Colon, Rectum | Prognosis | Sadat-Larijani M et al. Clin Lab. 2018 |
| 1862 | circulating cell-free nucleosomes (ccfn) | Colon, Rectum | Prognosis | Rasmussen L et al. Oncotarget. 2017 |
| 1864 | platelet count | Colon, Rectum | Prognosis | Rao XD et al. Medicine (Baltimore). 2018 |
| 1866 | KRAS(G13D) | Colon, Rectum | Diagnosis | Pierro C et al. Cell Calcium. 2018 |
| 1869 | Intestinal F. nucleatum | Colon, Rectum | Diagnosis | Peng BJ et al. Chin Med J (Engl). 2018 |
| 1872 | syndecan-2 (SDC2) methylation | Colon, Rectum | Diagnosis | Park YS et al. Gut Liver. 2018 |
| 1876 | exosome component 4 (EXOSC4) | Colon, Rectum | Diagnosis | Pan Y et al. Mol Carcinog. 2018 |
| 1879 | 15-glycogene | Colon, Rectum | Prognosis | Noda M et al. Clin Cancer Res. 2018 |
| 1884 | neutrophil-to-lymphocyte ratio(NLR), soluble programmed death-1 ligand-1(sPD-L1) | Colon, Rectum | Prognosis | Muneoka K et al. Gan To Kagaku Ryoho. 2018 |
| 1888 | SFRP1, SFRP2, NDRG4 and VIM | Colon, Rectum | Diagnosis | Mojtabanezhad Shariatpanahi A et al. PLoS One. 2018 |
| 1894 | novel radiomic signature | Rectum | Prognosis | Meng Y et al. J Magn Reson Imaging. 2018 |
| 1899 | vitamin D [25(OH)D3] | Colon, Rectum | Prognosis | Marques da Costa P et al. Clin Nutr. 2019 |
| 1901 | mast cells (MCs) | Colon, Rectum | Prognosis | Mao Y et al. Int J Cancer. 2018 |
| 1902 | retinol | Colon, Rectum | Prognosis | Maalmi H et al. Nutrients. 2018 |
| 1904 | rs3783553 polymorphism | Colon, Rectum | Prognosis | Ma Q et al. Int J Biol Markers. 2018 |
| 1926 | DCE-MRI | Colon, Rectum | Prognosis | Liu D et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018 |
| 1933 | FOSL2 | Colon | Prognosis | Li S et al. Exp Cell Res. 2018 |
| 1942 | Transcribed Ultraconserved Regions (T-UCRs) | Colon, Rectum | Prognosis | Kottorou AE et al. Oncotarget. 2018 |
| 1943 | ADAMTS16 | Colon, Rectum | Prognosis | Kordowski F et al. BMC Cancer. 2018 |
| 1949 | pre-operative neutrophil-to-lymphocyte ratio (NLR) | Rectum | Prognosis | Jones HG et al. Int J Colorectal Dis. 2018 |
| 1956 | LCK, GNLY, SLC6A6 and LAMP2 | Colon, Rectum | Diagnosis | Janikowska G et al. Cancer Biomark. 2018 |
| 1961 | alpha-smooth muscle actin (alpha-SMA) | Colon, Rectum | Prognosis | Ikuta D et al. Oncotarget. 2018 |
| 1966 | tumor-infiltrating CD57-positive lymphocytes (CD57(+) lymphocytes) | Colon, Rectum | Prognosis | Hu G et al. Oncotarget. 2017 |
| 1977 | oxidative stress | Colon, Rectum | Diagnosis | Gào X et al. Free Radic Biol Med. 2018 |
| 1981 | 5-flourouracil (5-FU) | Colon, Rectum | Prognosis | Gajjar KK et al. Int J Biol Markers. 2018 |
| 1986 | single nucleotide polymorphism (SNP) rs849142 | Colon, Rectum | Prognosis | Froelich MF et al. Oncotarget. 2018 |
| 1992 | vimentin | Colon, Rectum | Prognosis, Treatment | Du L et al. Biomed Res Int. 2018 |
| 1994 | SOCS3 | Colon, Rectum | Prognosis | Dong X et al. Oncotarget. 2017 |
| 2002 | Wnt/CTNNB1/miR183 signaling pathway | Colon, Rectum | Prognosis | Chen Y et al. Oncol Lett. 2018 |
| 2007 | RASGRF1 | Colon, Rectum | Prognosis | Chen H et al. Ann Clin Lab Sci. 2018 |
| 2013 | CDX2 | Colon, Rectum | Prognosis | Bruun J et al. Mol Oncol. 2018 |
| 2017 | Eyes Absent 4 (EYA4) | Colon, Rectum | Diagnosis | Barati Bagerabad M et al. Acta Med Iran. 2018 |
| 2018 | CD68+ | Colon, Rectum | Prognosis | Arelaki S et al. PLoS One. 2018 |
| 2025 | TSG BEND5 | Colon, Rectum | Prognosis | Lin RK et al. Oncotarget. 2017 |
| 2029 | Microsatellite instability (MSI) | Rectum | Prognosis | Hasan, S et al. Ann Surg. 2020 |
| 2031 | E-PASS | Colon, Rectum | Prognosis | Yamamoto, M et al. Dig Surg. 2020 |
| 2032 | The split scar sign | Rectum | Prognosis | Santiago, I et al. Eur Radiol. 2020 |
| 2034 | EMAST | Colon, Rectum | Prognosis, Treatment | Mohammadpour, S et al. J Cell Physiol. 2020 |
| 2038 | ITWG system | Colon, Rectum | Prognosis | Fuchs, T. L et al. Am J Surg Pathol. 2020 |
| 2041 | SorCS1 | Colon, Rectum | Prognosis | Huang, P. Z et al. Neoplasma. 2020 |
| 2042 | ITB | Colon, Rectum | Prognosis | Marx, A. H et al. Int J Colorectal Dis. 2020 |
| 2043 | Volatile organic compounds in breath | Colon, Rectum | Diagnosis | van Keulen, K. E et al. Aliment Pharmacol Ther. 2020 |
| 2044 | CRP + Monocyte Count | Colon, Rectum | Prognosis | Yamamoto, M et al. In Vivo. 2020 |
| 2047 | anti-TOPO48 autoantibody | Colon, Rectum | Diagnosis, Prognosis | Zhao, F et al. Biomarkers. 2020 |
| 2052 | Serum bicarbonate | Colon, Rectum | No Data | Chan, J. C. Y et al. PLoS One. 2020 |
| 2054 | F-NLR | Rectum | Prognosis | Sun, Y et al. World J Surg. 2020 |
| 2055 | Circulating basophil count | Colon, Rectum | Prognosis | Liu, Q et al. Clin Transl Med. 2020 |
| 2063 | Personalized indicator thrombocytosis (PIT) | Colon, Rectum | Treatment | Herold, Z et al. Cancers (Basel). 2020 |
| 2067 | CEA | Colon, Rectum | Prognosis | Gulhati, P et al. J Natl Cancer Inst. 2020 |
| 2070 | anoikis-resistant subpopulations | Colon, Rectum | Prognosis | Patankar, M et al. Apmis. 2020 |
| 2077 | C-reactive protein/albumin ratios (CAR) | Colon, Rectum | Prognosis | Matsuoka, H et al. Int J Clin Oncol. 2020 |
| 2079 | Sarcopenia | Colon, Rectum | Prognosis | Xie, H et al. Cancer Res Treat. 2020 |
| 2084 | Diffusion-weighted MRI (DWI) | Colon, Rectum | Prognosis | Takahashi, Y et al. Dig Dis Sci. 2021 |
| 2087 | microRNA-944 + EPHA7 | Colon, Rectum | Diagnosis | Shaker, O. G et al. Arch Physiol Biochem. 2020 |
| 2088 | The Pan-Immune-Inflammation Value | Colon, Rectum | Prognosis | Fucà, G et al. Br J Cancer. 2020 |
| 2091 | FT3/FT4 ratio | Colon, Rectum | Prognosis | Pasqualetti, G et al. Eur J Cancer. 2020 |
| 2094 | Baseline Splenic Volume | Colon, Rectum | Prognosis | Niogret, J et al. Cancers (Basel). 2020 |
| 2103 | ADCaqp | Rectum | Prognosis | Zhang, G et al. Sci Rep. 2020 |
| 2106 | Visceral Adiposity Index | Colon, Rectum | Diagnosis | Okamura, T et al. BMJ Open Gastroenterol. 2020 |
| 2109 | CSC markers and β-catenin/mTOR signaling | Colon, Rectum | Prognosis | Chang, J. Y et al. Yonsei Med J. 2020 |
| 2119 | Frailty | Rectum | Prognosis | Miller, S. M et al. Surgery. 2020 |
| 2121 | LCR | Colon, Rectum | Prognosis | Okugawa, Y et al. Ann Surg. 2020 |
| 2122 | 5-gene apoptotic biomarker | Colon, Rectum | Prognosis | Kosmidou, V et al. Eur J Clin Invest. 2021 |
| 2123 | TyG index | Colon, Rectum | Diagnosis | Okamura, T et al. BMC Endocr Disord. 2020 |
| 2126 | SOX2 and ABCC2 | Colon, Rectum | Prognosis | Kim, B. H et al. Anticancer Res. 2020 |
| 2128 | CYP24A1, PFDN4, lnc‐CYP24A1‐3:1, and lnc‐TSHZ2‐19:1 | Colon, Rectum | Diagnosis | Sadeghi, H et al. J Cell Physiol. 2021 |
| 2134 | LND | Colon, Rectum | Prognosis | Huang, X et al. Asian J Surg. 2021 |
| 2136 | CIN | Colon, Rectum | Prognosis | Nose, Y et al. Cancer Chemother Pharmacol. 2020 |
| 2142 | Hyponatremia | Colon, Rectum | Prognosis | Zhang, G et al. J Int Med Res. 2020 |
| 2143 | Radiomics nomogram | Rectum | Prognosis, Treatment | Chen, J et al. Abdom Radiol (NY). 2021 |
| 2150 | CMS | Colon, Rectum | Prognosis | Li, Y et al. Oncologist. 2020 |
| 2153 | Parvimonas micra | Colon, Rectum | Prognosis | Löwenmark, T et al. Sci Rep. 2020 |
| 2159 | Apparent diffusion coefficient | Rectum | Treatment | Jiménez de Los Santos, M. E et al. Acta Radiol Open. 2020 |
| 2160 | FARI | Rectum | Prognosis | Lu, S et al. Cancer Manag Res. 2020 |
| 2162 | Tumour-stroma ratio | Colon, Rectum | Prognosis | Zhao, K et al. EBioMedicine. 2020 |
| 2163 | oral microbiome | Colon, Rectum | Prognosis | Zhang, S et al. Theranostics. 2020 |
| 2168 | Deoxyuridine | Colon, Rectum | Treatment | Taflin, H et al. Cancer Chemother Pharmacol. 2021 |
| 2171 | Diameter of Superior Rectal Vein | Rectum | Prognosis | Song, C et al. Cancer Manag Res. 2020 |
| 2175 | MYC | Colon, Rectum | Prognosis | Tong, Y et al. Front Genet. 2020 |
| 2180 | LWR | Colon, Rectum | Prognosis | Ang, J. J et al. J Surg Res. 2021 |
| 2182 | Albumin-Bilirubin Grade | Colon, Rectum | Prognosis | Zhu, C et al. Cancer Manag Res. 2020 |
| 2183 | Three-DNA Methylation | Colon, Rectum | Prognosis | Gong, S et al. Biomed Res Int. 2020 |
| 2190 | Pathological response | Rectum | Prognosis | On, J et al. Colorectal Dis. 2021 |
| 2194 | P-CRP | Rectum | Prognosis, Treatment | Ide, S et al. Int J Clin Oncol. 2021 |
| 2197 | Metabolic syndrome | Colon, Rectum | Prognosis | Bhome, R et al. Eur J Surg Oncol. 2021 |
| 2198 | M+ PRL-3+ | Colon, Rectum | Prognosis | Su, P et al. Clin Transl Gastroenterol. 2020 |
| 2199 | Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila | Colon, Rectum | Prognosis | Osman, M. A et al. Sci Rep. 2021 |
| 2200 | Expression Pattern Among Different Immune Cell | Colon, Rectum | Prognosis | Xu, X et al. J Histochem Cytochem. 2021 |
| 2209 | lymphocyte count and albumin concentration | Rectum | Prognosis | Yamamoto, T et al. Sci Rep. 2021 |
| 2216 | Protease cargo | Colon, Rectum | Prognosis | Yunusova, N. V et al. Asian Pac J Cancer Prev. 2021 |
| 2219 | Rad-score | Colon, Rectum | Prognosis | Fan, S et al. Front Oncol. 2021 |
| 2222 | Apparent diffusion coefficient (ADC) | Rectum | Diagnosis | Li, J et al. Cancer Manag Res. 2021 |
| 2223 | CEA-R | Colon, Rectum | Prognosis | Suzuki, Y et al. Int J Clin Oncol. 2021 |
| 2228 | Nutritional index + excessive intraoperative blood loss | Rectum | Prognosis | Paku, M et al. BMC Cancer. 2021 |
| 2229 | Tumor budding | Colon, Rectum | Prognosis, Treatment | Akabane, S et al. Int J Clin Oncol. 2021 |
| 2234 | Magnetic resonance imaging R0-R1 | Colon, Rectum | Prognosis | Westberg, K et al. Eur J Surg Oncol. 2021 |
| 2239 | LCR | Colon, Rectum | Prognosis | Okugawa, Y et al. Surg Today. 2021 |
| 2242 | Peritoneal cytology | Colon, Rectum | Prognosis | Sugarbaker, P. H et al. J Surg Oncol. 2021 |
| 2247 | Radiomics signature | Colon, Rectum | Prognosis | Zhang, Z et al. Diagn Interv Radiol. 2021 |
| 2248 | Free Fatty Acid | Colon, Rectum | Diagnosis | Zhu, B et al. Cancer Manag Res. 2021 |
| 2249 | Calcium | Rectum | Prognosis | Zhuang, Z et al. J Gastrointest Oncol. 2021 |
| 2253 | CEA + PNI | Colon, Rectum | Prognosis | Uejima, C et al. Yonago Acta Med. 2021 |
| 2254 | Radiomics Signature | Rectum | Prognosis | Zhang, Z et al. Front Oncol. 2021 |
| 2255 | Fatty Acid Unsaturation | Colon, Rectum | Prognosis | Bestard-Escalas, J et al. Int J Mol Sci. 2021 |
| 2259 | VSR | Colon, Rectum | Prognosis | He, A. Q et al. Med Sci Monit. 2021 |
| 2260 | CEA | Colon, Rectum | Prognosis | Sonoda, H et al. Eur J Surg Oncol. 2021 |
| 2261 | TP53 + Intratumoural Budding + CD8+ T-cell Density | Rectum | Prognosis | Chen, W et al. Histopathology. 2021 |
| 2264 | CTCs | Colon, Rectum | Prognosis | Pan, R. J et al. Cancer Manag Res. 2021 |
| 2268 | CD45RO+T cells | Rectum | Prognosis | Zhai, Z et al. Medicine (Baltimore). 2021 |
| 2271 | GSSG/GSH | Colon, Rectum | Diagnosis, Prognosis | Acevedo-León, D et al. Int J Mol Sci. 2021 |
| 2276 | Clinicopathologic index of inflammation and nutrition | Colon, Rectum | Prognosis | Wu, G et al. Front Oncol. 2021 |
| 2277 | TB | Colon, Rectum | Prognosis | Shin, J. K et al. Ann Surg Oncol. 2021 |
| 2278 | PLR | Colon, Rectum | Prognosis | Fu, Y et al. BMC Cancer. 2021 |
| 2280 | CEA | Colon, Rectum | Prognosis | Moretto, R et al. Br J Cancer. 2021 |
| 2285 | GNRI | Colon, Rectum | Prognosis | Kato, M et al. Dig Endosc. 2022 |
| 2286 | cRPV | Rectum | Prognosis | Cho, E et al. Cancers (Basel). 2021 |
| 2288 | Radiological psoas muscle area measurement | Rectum | Prognosis | Uehara, H et al. Surg Today. 2022 |
| 2297 | serum CEA levels | Rectum | Treatment | Huang, C et al. Front Oncol. 2021 |
| 2300 | SHP | Rectum | Prognosis, Treatment | Kim, S et al. Oncol Lett. 2021 |
| 2305 | CTCs | Colon, Rectum | Prognosis | Shen, F et al. Colorectal Dis. 2022 |
| 2306 | Bisulfate Conversion-Free Detection of Fecal DNA Methylation | Colon, Rectum | Prognosis | Liu, C et al. Biomed Res Int. 2021 |
| 2310 | Scatter patterns in lymph node metastases | Colon, Rectum | Prognosis | Koike, T et al. Mol Clin Oncol. 2021 |
| 2312 | N6-Methyladenosine RNA Levels | Colon, Rectum | Prognosis | Xie, J et al. Front Immunol. 2021 |
| 2314 | CIPI | Colon, Rectum | Prognosis, Treatment | Su, Y. L et al. Cancers (Basel). 2021 |
| 2320 | LMRG | Colon, Rectum | Prognosis | Yang, C et al. BMC Cancer. 2021 |
| 2321 | Age of onset | Rectum | Prognosis | Foppa, C et al. Eur J Surg Oncol. 2022 |
| 2326 | multi-parametric MRI | Rectum | Prognosis | Zhou, Y et al. BMC Med Imaging. 2021 |
| 2328 | Skin toxicity | Colon, Rectum | Prognosis | Ciardiello, D et al. Cancers (Basel). 2021 |
| 2330 | ADC values | Rectum | Prognosis | Kargol, J et al. Med Sci Monit. 2021 |
| 2333 | MYO1-G | Colon, Rectum | Diagnosis | Lin, W. H et al. Clin Epigenetics. 2021 |
| 2334 | CK20 + CLIP4 | Colon, Rectum | Diagnosis | Liu, Z et al. Aging (Albany NY). 2021 |
| 2336 | Prevotella copri (Pc), Gemella morbillorum (Gm), Parvimonas micra (Pm), Cetobacterium somerae (Cs), and Pasteurella stomatis (Ps) | Colon, Rectum | Diagnosis | Yao, Y et al. Front Cell Infect Microbiol. 2021 |
| 2337 | apoB‑to‑apoAI ratio | Rectum | Prognosis | Chen, C et al. BMC Cancer. 2022 |
| 2338 | EMVI | Rectum | Diagnosis | Abe, T et al. World J Surg Oncol. 2022 |
| 2340 | FCEA | Colon, Rectum | Diagnosis | Li, L et al. Therap Adv Gastroenterol. 2021 |
| 2342 | Blood cholesterol-to-lymphocyte ratio | Colon, Rectum | Prognosis | Zhou, S et al. World J Surg Oncol. 2022 |
| 2354 | DLX6-AS1 Methylation | Colon, Rectum | Prognosis | Lin, S et al. Front Oncol. 2021 |
| 2355 | RRM2B | Colon, Rectum | Prognosis | Mobarra, N et al. Mol Biol Rep. 2022 |
| 2367 | Preoperative Neutrophil-BMI Ratio | Colon, Rectum | Prognosis | Xie, W et al. Technol Cancer Res Treat. 2022 |
| 2372 | Treg density | Colon, Rectum | Prognosis | Oshi, M et al. Am J Cancer Res. 2022 |
| 2373 | NSAP | Colon, Rectum | Prognosis | Cai, X et al. World J Surg Oncol. 2022 |
| 2374 | NLR + LMR | Rectum | Prognosis | Zhang, J et al. Sci Rep. 2022 |
| 2379 | miR‑31‑5p‑DMD axis | Colon, Rectum | Prognosis | Liu, C et al. Oncol Lett. 2022 |
| 2381 | Inflammation-based Indexes | Colon, Rectum | Prognosis, Treatment | Satake, M et al. Cancer Diagn Progn. 2022 |
| 2382 | TYMS-TM4SF4 axis | Colon, Rectum | Prognosis | Zhang, F et al. Am J Cancer Res. 2022 |
| 2383 | Drug resistant score model (DRSM) | Colon, Rectum | Prognosis, Treatment | Chen, L et al. Front Oncol. 2022 |
| 2384 | LNM assessment model | Colon, Rectum | Prognosis | Fu, J et al. PeerJ. 2022 |
| 2385 | Baseline soluble MICA levels | Colon, Rectum | Treatment | Arai, J et al. BMC Cancer. 2022 |
| 2387 | Fusobacterium nucleatum | Colon, Rectum | Diagnosis, Prognosis | Zhang, X et al. iScience. 2022 |
| 2391 | Perineural invasion | Colon, Rectum | Prognosis | Li, J et al. J Gastrointest Oncol. 2022 |
| 2392 | BMI | Colon, Rectum | Prognosis | Takeyama, H et al. J Anus Rectum Colon. 2022 |
| 2393 | Neutrophils and necrosis | Colon, Rectum | Prognosis | Jakubowska, K et al. Oncol Lett. 2022 |
| 2394 | Circulating Glycan Monosaccharide Composite | Colon, Rectum | Diagnosis, Prognosis | Li, H et al. Front Oncol. 2022 |
| 2400 | SGFR | Colon, Rectum | Prognosis | Chen, S et al. Front Oncol. 2022 |
| 2406 | [89Zr]Zr-cetuximab | Colon, Rectum | Treatment | van Helden, E. J et al. Eur J Nucl Med Mol Imaging. 2020 |
| 2408 | 18F-FDG-PET/CT | Colon, Rectum | Prognosis, Treatment | Nakamura, M et al. Oncol Ther. 2021 |
| 2410 | Presence of Ascites | Colon, Rectum | Prognosis | Said, I et al. Ann Surg Oncol. 2022 |
| 2414 | DDIR | Colon, Rectum | Treatment | Malla, S. B et al. Clin Cancer Res. 2021 |
| 2415 | MammaPrint | Colon, Rectum | No Data | Dubsky, P et al. ESMO Open. 2021 |
| 2420 | The lymph node ratio (LNR) | Rectum | Prognosis | Karjol, U et al. Cureus. 2020 |
| 2423 | Log odds of positive lymph nodes | Colon, Rectum | Prognosis | Li, Y et al. BMC Cancer. 2022 |
| 2425 | Kallikrein-related peptidases | Colon, Rectum | Prognosis | Peng, Q et al. Cancer Cell Int. 2020 |
| 2435 | Glasgow prognostic score (GPS) | Colon, Rectum | Prognosis | Lu, X et al. Cancer Manag Res. 2019 |